These studies demonstrate that TRPV1 is not only a key channel for drug and noise uptake but also an important mediator of inflammatory responses, offering potential therapeutic targets for the prevention and treatment of hearing loss. The gene discussed is TRPV1; the disease is hearing loss disorder.